High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.3M
$1,305,390
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CRBP
S
Corbus Pharmaceuticals Holdings, Inc.
Smethurst Dominic
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$50,601
|
||||||
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $50,601 | S | Form 4 |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
COO
Sell to Cover
|
2026-02-17 | $6,253 | S | Form 4 |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
CEO
Sell to Cover
|
2026-02-13 | $107,952 | S | Form 4 |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
CFO
Sell to Cover
|
2026-02-13 | $36,588 | S | Form 4 |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
COO
Sell to Cover
|
2026-02-03 | $19,537 | S | Form 4 |
|
CRBP
S
Corbus Pharmaceuticals Holdings, Inc.
Smethurst Dominic
• Officer • Chief Medical Officer
Sell to Cover
2026-02-03
$26,575
|
||||||
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-02-03 | $26,575 | S | Form 4 |
|
CRBP
S
Corbus Pharmaceuticals Holdings, Inc.
Cormorant Asset Management, LP
• 10% Owner
Discretionary Sell
2025-12-11
$344,012
|
||||||
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
10% Owner
Discretionary Sell
|
2025-12-11 | $344,012 | S | Form 4 |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
CEO
10b5-1 Sell
|
2025-10-27 | $153,797 | S | Form 4 |
|
CRBP
S
Corbus Pharmaceuticals Holdings, Inc.
Cohen Yuval
• CEO
10b5-1 SellΔOwn -11.9%
2025-10-24
$317,407
|
||||||
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
CEO
10b5-1 SellΔOwn -11.9%
|
2025-10-24 | $317,407 | S | Form 4 |
|
CRBP
S
Corbus Pharmaceuticals Holdings, Inc.
Moran Sean F.
• CFO
10b5-1 SellΔOwn -15.0%
2025-10-24
$220,937
|
||||||
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
CFO
10b5-1 SellΔOwn -15.0%
|
2025-10-24 | $220,937 | S | Form 4 |
|
CRBP
S
Corbus Pharmaceuticals Holdings, Inc.
Altmeyer Anne
• Director
10b5-1 SellΔOwn -14.6%
2025-10-20
$21,730
|
||||||
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
Director
10b5-1 SellΔOwn -14.6%
|
2025-10-20 | $21,730 | S | Form 4 |